Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Endometrial Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Proteus Syndrome 1Ovarian Neoplasms 1Lymphoma 1

Interventions

Miransertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Proteus Syndrome × Miransertib × Clear all
NCT02594215 2022-06-30

Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
6 enrolled

Proteus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡